Drug application
MERETEK UBT KIT (W/ PRANACTIN) (UREA C-13)
Drugs@FDA NDA 020586 · OTSUKA AMERICA
Key facts
| Drug name | MERETEK UBT KIT (W/ PRANACTIN) |
|---|---|
| Active ingredients | UREA C-13 |
| Application type | NDA |
| Application number | 020586 |
| Company | OTSUKA AMERICA |
| Dosage forms | FOR SOLUTION, ORAL |
| Strength | 125MG/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 1 - New Molecular Entity |
| Latest submission status date | Sep 17, 1996 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: